Switzerland’s Sandoz files antitrust lawsuit against Amgen in US

(Reuters) -Swiss generic drug manufacturer Sandoz said on Monday it had filed an antitrust lawsuit in the U.S. against Amgen for entrenching the dominant market position of its blockbuster medicine, Enbrel (etanercept).

(Reporting by Abinaya Vijayaraghavan; Editing by Rashmi Aich)